Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CV Sciences, Inc.CVSI · Entity 8316 | Chief Financial Officer | February 18, 2025 | February 20, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CV Sciences, Inc.
Report date February 18, 2025 · Filed February 20, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.04 · Expires 2035-02-17 | Direct | 2,350,000 |
Reported balance
After 2025-02-18 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-02-18 · Grant · Acquired 2,350,000 · Balance 2,350,000 F1: The option is durational-based. No option shares are vested on the date of grant. The option shares vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from February 18, 2025, provided, that there has not been a termination of service as of such date. In no event will any unvested portion of the option vest or become exercisable for any additional option shares after the termination of service. |
Filing footnotes · ownership attribution and instrument terms
F1: The option is durational-based. No option shares are vested on the date of grant. The option shares vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from February 18, 2025, provided, that there has not been a termination of service as of such date. In no event will any unvested portion of the option vest or become exercisable for any additional option shares after the termination of service.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 18, 2025 Filed Feb 20, 2025 22:28 UTC | CV Sciences, Inc. CVSI · Entity 8316 | GrantEmployee Stock Option (right to buy) · Derivative | 2,350,000 | $0.00 Strike: $0.04 | $0.00 |
DisclosureSEC source: 0000950170-25-024329 · ownership.xml · derivative · entry 1 Grasser Joerg · CIK 0001763727 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,350,000 Underlying: Common Stock · 2,350,000 shares Expires 2035-02-17 F1 · derivative.exercise_date: The option is durational-based. No option shares are vested on the date of grant. The option shares vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from February 18, 2025, provided, that there has not been a termination of service as of such date. In no event will any unvested portion of the option vest or become exercisable for any additional option shares after the termination of service. Read SEC document |
| June 20, 2024 Filed Jun 24, 2024 21:30 UTC | CV Sciences, Inc. CVSI · Entity 8316 | GrantEmployee Stock Option (right to buy) · Derivative | 2,350,000 | $0.00 Strike: $0.05 | $0.00 |
DisclosureSEC source: 0000950170-24-076912 · ownership.xml · derivative · entry 1 Grasser Joerg · CIK 0001763727 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,350,000 Underlying: Common Stock · 2,350,000 shares Expires 2034-06-19 F1 · derivative.exercise_date: The option is durational-based. No option shares are vested on the date of grant. The option shares vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from June 20, 2024, provided, that there has not been a termination of service as of such date. In no event will any unvested portion of the option vest or become exercisable for any additional option shares after a termination of service. Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 20:43 UTC | CV Sciences, Inc. CVSI · Entity 8316 | GrantEmployee Stock Option (right to buy) · Derivative | 1,250,000 | $0.00 Strike: $0.04 | $0.00 |
DisclosureSEC source: 0001510964-23-000008 · wf-form4_167908577042844.xml · derivative · entry 1 Grasser Joerg · CIK 0001763727 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,250,000 Underlying: Common Stock · 1,250,000 shares Expires 2033-03-14 F1 · derivative.exercise_date: The option is durational-based. No option shares are vested on the date of grant. The option shares vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from March 15, 2023, provided, that there has not been a termination of service as of such date. In no event will any unvested portion of the option vest or become exercisable for any additional option shares after a termination of service. Read SEC document |
| March 30, 2022 Filed Apr 2, 2022 00:22 UTC | CV Sciences, Inc. CVSI · Entity 8316 | Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 250,000 | Not disclosed Strike: $0.66 | Not disclosed |
DisclosureSEC source: 0001510964-22-000027 · wf-form4_164885893634966.xml · derivative · entry 4 Grasser Joerg · CIK 0001763727 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 250,000 shares Expires 2028-12-25 F2 · price: On March 30, 2022, the stock options were cancelled by mutual agreement of the reporting person and the issuer. The reporting person received an aggregate of $100 as consideration for the cancellation. F3 · derivative.exercise_date: The option is durational based. All option shares were vested and exercisable on the date of cancellation. Read SEC document |
| March 30, 2022 Filed Apr 2, 2022 00:22 UTC | CV Sciences, Inc. CVSI · Entity 8316 | Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 250,000 | Not disclosed Strike: $0.66 | Not disclosed |
DisclosureSEC source: 0001510964-22-000027 · wf-form4_164885893634966.xml · derivative · entry 3 Grasser Joerg · CIK 0001763727 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 250,000 shares Expires 2029-03-14 F2 · price: On March 30, 2022, the stock options were cancelled by mutual agreement of the reporting person and the issuer. The reporting person received an aggregate of $100 as consideration for the cancellation. F3 · derivative.exercise_date: The option is durational based. All option shares were vested and exercisable on the date of cancellation. Read SEC document |
| March 30, 2022 Filed Apr 2, 2022 00:22 UTC | CV Sciences, Inc. CVSI · Entity 8316 | Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 750,000 | Not disclosed Strike: $0.33 | Not disclosed |
DisclosureSEC source: 0001510964-22-000027 · wf-form4_164885893634966.xml · derivative · entry 2 Grasser Joerg · CIK 0001763727 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 750,000 shares Expires 2030-03-19 F2 · price: On March 30, 2022, the stock options were cancelled by mutual agreement of the reporting person and the issuer. The reporting person received an aggregate of $100 as consideration for the cancellation. F3 · derivative.exercise_date: The option is durational based. All option shares were vested and exercisable on the date of cancellation. Read SEC document |
| March 30, 2022 Filed Apr 2, 2022 00:22 UTC | CV Sciences, Inc. CVSI · Entity 8316 | Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 750,000 | Not disclosed Strike: $0.59 | Not disclosed |
DisclosureSEC source: 0001510964-22-000027 · wf-form4_164885893634966.xml · derivative · entry 1 Grasser Joerg · CIK 0001763727 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 750,000 shares Expires 2031-03-08 F2 · price: On March 30, 2022, the stock options were cancelled by mutual agreement of the reporting person and the issuer. The reporting person received an aggregate of $100 as consideration for the cancellation. F1 · derivative.exercise_date: The option is durational based. 375,000 option shares were vested and exercisable on the date of cancellation. Twenty-five (25%) of the option shares were scheduled to vest and become exercisable on September 1, 2022 and March 1, 2023, provided, that there was no termination of service as of such date. Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 21:56 UTC | CV Sciences, Inc. CVSI · Entity 8316 | GrantEmployee Stock Option (right to buy) · Derivative | 750,000 | $0.00 Strike: $0.59 | $0.00 |
DisclosureSEC source: 0001510964-21-000005 · wf-form4_161549975322122.xml · derivative · entry 1 Grasser Joerg · CIK 0001763727 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 750,000 Underlying: Common Stock · 750,000 shares Expires 2031-03-08 F1 · derivative.exercise_date: The option is durational-based. No option shares are vested on the date of grant. Twenty-five percent (25%) of the option shares vest and become exercisable on each of the following dates: September 1, 2021, March 1, 2022, September 1, 2022, and March 1, 2023, provided, that there has not been a termination of service as of such date. In no event will any unvested portion of the option vest or become exercisable for any additional option shares after a termination of service. Read SEC document |
| March 20, 2020 Filed Mar 25, 2020 01:52 UTC | CV Sciences, Inc. CVSI · Entity 8316 | GrantEmployee Stock Option (right to buy) · Derivative | 750,000 | $0.33 Strike: $0.33 | $247,500.00 |
DisclosureSEC source: 0001510964-20-000018 · wf-form4_158510115632537.xml · derivative · entry 1 Grasser Joerg · CIK 0001763727 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 750,000 Underlying: Common Stock · 750,000 shares Expires 2030-03-19 F1 · derivative.exercise_date: The option is durational-based. 250,000 option shares vested on the grant date, 250,000 option shares vest and become exercisable on April 15, 2020 and the remaining 250,000 option shares vest and become exercisable on July 15, 2020, provided, however, that there has not been a termination of service as of such date. In no event will the option become exercisable for any additional option shares after a termination of service. Read SEC document |
| November 07, 2019 Filed Nov 7, 2019 21:02 UTC | CV Sciences, Inc. CVSI · Entity 8316 | PurchaseCommon Stock | 15,000 | $1.49 | $22,288.50 |
DisclosureSEC source: 0001510964-19-000068 · wf-form4_157316056381969.xml · nonDerivative · entry 1 Grasser Joerg · CIK 0001763727 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 F1 · price: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.47 to $1.49 per share, inclusive. F2 · price: The reporting person undertakes to provide CV Sciences, Inc., any security holder of CV Sciences, Inc., or the staff of the Securities and Exchange Commission, upon request, the full information regarding the number of shares purchased at each seperate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| March 15, 2019 Filed Mar 25, 2019 12:22 UTC | CV Sciences, Inc. CVSI · Entity 8316 | GrantEmployee Stock Option (right to buy) · Derivative | 250,000 | $0.00 Strike: $4.67 | $0.00 |
DisclosureSEC source: 0001683168-19-000765 · ownership.xml · derivative · entry 1 Grasser Joerg · CIK 0001763727 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2029-03-14 F1 · derivative.exercise_date: The option is durational-based. No option shares are vested on the date of grant and the remaining option shares vest and become exercisable as follows: (i) thirty-three percent (33%) of the option shares vest and become exercisable on the one (1) year anniversary of December 26, 2018, provided, however, that there has not been a termination of service as of such date and (ii) the balance of the option shares will vest and become exercisable in a series of twenty-four (24) successive equal monthly installments measured from the first anniversary of December 26, 2018, provided, however, that there has not been a termination of service as of each such date. In no event will the option become exercisable for any additional option shares after a termination of service. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.